According to a new report Global Biochips Market, published by KBV research, The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period.
The North America market dominated the Global DNA Chip Market by Region in 2018, growing at a CAGR of 10.2% during the forecast period. The Europe market is expected to witness a CAGR of 10.5% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12.4% during (2019 - 2025).
The Drug Discovery and Development market dominated the Global Biochips Market by Application in 2018, growing at a CAGR of 10.9 % during the forecast period. The Disease Diagnostics market is expected to witness a CAGR of 10.8% during (2019 - 2025).
The Biotechnology and Pharmaceutical Sector market dominated the Global Biochips Market by End User in 2018, growing at a CAGR of 10.9 % during the forecast period. The Hospitals and Diagnostics Centers market is expected to witness a CAGR of 10.8% during (2019 - 2025). The Academic and Research Institutes market is expected to witness a CAGR of 12.6% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/biochips-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.
ByProduct
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
